1125 Unit 3 Client needs related to selected thought and cognitive alterations
SCHIZOPHRENIA SPECTRUM DISORDERS
Range of disorders with psychotic symptoms
No cure available
Characteristics
Disconnect from reality leading to:
Hallucinations- involve feeling seeing or hearing things that others do not experience.
Vivid, clear experiences of altered perception without external stimuli
Delusions
False beliefs such as persecution or grandeur
Emotional changes
Withdrawal from social interactions
Lack of self-care
Impact on Life
Individuals can lead productive lives with treatment and support.
Stigma affects access to healthcare leading to:
Underdiagnoses
Undertreatment
High prevalence of co-occurring mental health disorders (50%)
Typical age of diagnosis: 16-30 years
Increased risk of becoming victims of crime or violence (14X)
Elevated risk for premature mortality
5% die by suicide. average life expectancy 28.5 years
TYPES OF DISORDERS
Schizophrenia - A chronic and severe mental disorder that affects how a person thinks, feels, and behaves, often leading to a detachment from reality.
Schizotypal Personality Disorder: Impairments in personality functioning, less severe than schizophrenia.
Delusional Disorder: Delusional thinking for at least 1 month; self or interpersonal functioning not markedly impaired.
Brief Psychotic Disorder: Psychotic manifestations lasting from 1 day to 1 month.
Schizophreniform Disorder: Similar symptoms to schizophrenia lasting from 1 to 6 months; social/occupational dysfunction may not be apparent.
Schizoaffective Disorder: Criteria for both schizophrenia and a mood disorder.
Substance-Induced Psychosis: Psychosis due to substance use or withdrawal.
DIAGNOSIS CRITERIA
Psychotic thinking or behavior present for at least 6 months.
Significant impairment in school/work, self-care, or interpersonal relationships.
ETIOLOGY
Genetics:
Multiple genes contribute to vulnerability
Physiological:
Neurodevelopment, hypoxia, infections
Biochemical:
Chronic cortisol exposure
Environmental:
Cannabis use
SYMPTOMS
Positive Symptoms:
Hallucinations
Delusions
Disorganized speech
Bizarre behavior
Negative Symptoms:
Affect blunting
Alogia (lack of speech)
Anergia (lack of energy)
Anhedonia (lack of pleasure)
Cognitive Symptoms:
Poor concentration
Slow thinking
Poor memory
THERAPEUTIC RELATIONSHIP PHASES
Orientation
Identification
Exploitation
Resolution
CHALLENGES IN THERAPY
Clients may not recognize need for help.
Family/friends unable to assist due to client history.
Manifestations of psychosis affecting communication.
INTERVENTIONS FOR SUPPORT
Creating a safe therapeutic relationship.
Advocating for early detection.
Complete mental status exams.
Focusing on stabilizing interventions & recovery.
TREATMENT APPROACHES
Recovery-oriented care including:
Medications
Cognitive behavioral therapy
Family education and support
Assertive community treatment
CLIENT TEACHING PRIORITIES
Discharge instructions on medications, diet, and exercise.
Signs of relapse & referrals for continued support.
MEDICATIONS
Antipsychotics:
1st Generation: Treat positive symptoms, e.g., Haloperidol.
2nd Generation: Treat both positive and negative symptoms, e.g., Risperidone, Olanzapine.
3rd Generation: Improve cognitive function, e.g., Aripiprazole.
Adjunct Medications:
Antidepressants for depression linked to psychotic disorders, e.g., Paroxetine.
Mood Stabilizers for anxiety, e.g., Lamotrigine.
ADVERSE EFFECTS OF ANTIPSYCHOTICS
Akathisia, tardive dyskinesia, Parkinsonism.
Dystonia, impulse control disorders, sedation.
Orthostatic hypotension, metabolic effects, agranulocytosis.
SOCIAL AND ECONOMIC CHALLENGES
Social Problems:
Stigma and isolation
Increased victimization
Economic Challenges:
Unemployment and homelessness
Caregiver burden
NEUROCOGNITIVE DISORDERS
Delirium: Short-term cognitive disturbance and attention issue.
Dementia: Chronic cognitive decline with several variants.
Assessment Criteria:
Focus on distinguishing between delirium and dementia based on onset, cognition, and emotional state.
NURSE'S ROLE
Provide equitable and sensitive care based on knowledge and empathy.
Safety monitoring and advocacy to ensure least restrictive environment.
Education and support for families.
ASSESSMENT AND EVALUATION
Regular assessment of cognition and caregiver strain.
Monitor medication effectiveness and adherence.